PAPER Xu L, Mahairaki V, Koliatsos VE
SEARCH RESULTS
331202 RESULTS
PAPER Reilmann R
An important step towards translation of stem cell therapies in clinical applications for neurodegenerative diseases and beyond?
Mov Disord. 2012 Sep 15;27(11):1355-6. PubMed: 23166927PAPER Cardoner N, Soria V, Gratacòs M, Hernández-Ribas R, Pujol J, López-Solà M, Deus J, Urretavizcaya M, Estivill X, Menchón JM, Soriano-Mas C
VAL66MET BDNF GENOTYPES IN MELANCHOLIC DEPRESSION: EFFECTS ON BRAIN STRUCTURE AND TREATMENT OUTCOME.
Depress Anxiety. 2012 Nov 16; PubMed: 23165919PAPER Xiao XL, Ma DL, Wu J, Tang FR
Metabotropic glutamate receptor 5 (mGluR5) regulates proliferation and differentiation of neuronal progenitors in the developmental hippocampus.
Brain Res. 2013 Feb 1;1493:1-12. PubMed: 23165119PAPER Moyle W, Murfield JE, O'Dwyer S, Van Wyk S
The effect of massage on agitated behaviours in older people with dementia: a literature review.
J Clin Nurs. 2013 Mar;22(5-6):601-610. PubMed: 23164052PAPER Kövari E, Herrmann FR, Hof PR, Bouras C
The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease.
Neuropathol Appl Neurobiol. 2012 Nov 16; PubMed: 23163235PAPER Richman M, Perelman A, Gertler A, Rahimipour S
Effective targeting of aβ to macrophages by sonochemically prepared surface-modified protein microspheres.
Biomacromolecules. 2013 Jan 14;14(1):110-6. PubMed: 23163430PAPER Slowik A, Merres J, Elfgen A, Jansen S, Mohr F, Wruck CJ, Pufe T, Brandenburg LO
Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE)--and amyloid beta 1-42-induced signal transduction in glial cells.
Mol Neurodegener. 2012;7:55. PubMed: 23164356PAPER Filippi M, Agosta F, Scola E, Canu E, Magnani G, Marcone A, Valsasina P, Caso F, Copetti M, Comi G, Cappa SF, Falini A
Functional network connectivity in the behavioral variant of frontotemporal dementia.
Cortex. 2012 Oct 24; PubMed: 23164495PAPER Greenberg BD, Carrillo MC, Ryan JM, Gold M, Gallagher K, Grundman M, Berman RM, Ashwood T, Siemers ER
Improving Alzheimer's disease phase II clinical trials.
Alzheimers Dement. 2013 Jan;9(1):39-49. PubMed: 23164548PAPER Kawas CH, Greenia DE, Bullain SS, Clark CM, Pontecorvo MJ, Joshi AD, Corrada MM
Amyloid imaging and cognitive decline in nondemented oldest-old: The 90+ Study.
Alzheimers Dement. 2012 Nov 16; PubMed: 23164550PAPER Ting SK, Hameed S, Earnest A, Tan EK
Dissociative semantic breakdown in Alzheimer's disease: Evidence from multiple category fluency test.
Clin Neurol Neurosurg. 2012 Nov 16; PubMed: 23164607PAPER Rizzo S, Tarozzi A, Bartolini M, da Costa G, Bisi A, Gobbi S, Belluti F, Ligresti A, Allarà M, Monti JP, Andrisano V, Di Marzo V, Hrelia P, Rampa A
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents.
Eur J Med Chem. 2012 Dec;58:519-32. PubMed: 23164658PAPER O'Hare E, Scopes DI, Kim EM, Palmer P, Jones M, Whyment AD, Spanswick D, Amijee H, Nerou E, McMahon B, Treherne JM, Jeggo R
Orally bioavailable small molecule drug protects memory in Alzheimer's disease models.
Neurobiol Aging. 2013 Apr;34(4):1116-25. PubMed: 23164690PAPER Brown BM, Peiffer JJ, Martins RN
Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer's disease?
Mol Psychiatry. 2012 Nov 20; PubMed: 23164816Current Filters
No filters selected